News
| 4 min read
A team of physicians performed double duty as scientists and research subjects for a recent study that cautions against prematurely resuming social activities during the pandemic.
| 2 min read
Pyxis Oncology closes $152-million Series B financing to further advance portfolio
| 2 min read
New Mount Sinai study identifies a novel approach for tailored treatment that could be more effective for patients
| 3 min read
Unique AI method developed at Chalmers for generating proteins could speed up drug development
| 3 min read
Wild Biotech says it is discovering millions of previously unknown potential human therapeutics
| 2 min read
New discoveries suggest it is on par with therapeutics and speeds the process of recovery and adoption of personalized treatment
| 2 min read
EMA grants Orphan Drug designation to JR-171 for the treatment of mucopolysaccharidosis type I
| 2 min read
Bioasis announces publication evaluating CNS delivery of siRNA via the company’s xB³ platform
| 4 min read
Decision provides a consistent standard based on structure even though resulting scope may prove insufficient for justifying costs of commercialization
| 2 min read
Bright Peak Therapeutics and Ajinomoto enter into research collaboration for novel immunocytokines
| 4 min read
A study published in Nature Medicine points to saliva’s role in SARS-CoV-2 transmission
| 3 min read
BetterLife enters research agreement with UCSD for TD-0148A behavioral pharmacology studies
